Daphne Quimi - Jan 17, 2023 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role: Chief Financial Officer
Signature: /s/ Christian Formica, Attorney-in-Fact
Stock symbol: FOLD
Transactions as of: Jan 17, 2023
Transactions value $: -$152,444
Form type: 4
Date filed: 1/19/2023, 05:16 PM
Previous filing: Jan 13, 2023
Next filing: Jun 12, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FOLD	Common Stock	Sale	-$62.4K	-5K	-1.22%	$12.49	405K	Jan 17, 2023	Direct	F1, F2
transaction	FOLD	Common Stock	Sale	-$90K	-6.92K	-1.71%	$13.00	399K	Jan 18, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2	This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.34 to $12.70. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.34 to $12.70. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.